MACC1 and colorectal carcinoma: In conclusion, our study revealed that plasma MACC1 is a clinical relevant biomarker in diagnosis and prognosis in CRC, and the incorporation of MACC1 levels with other stratified clinical parameters could improve their prognostic values for CRC subpopulations.